Languages
简体中文
繁體中文
English
日本語
한국어
Bahasa Indonesia
Tiếng Việt
Sign In
Send a Release
Products
News
Resources
Contact
Search
Search
Products
News
Resources
Contact
Overview
Content Creation
Distribution
Monitoring & Insights
Influencer Database
Falcon
All Products
Send a Release
News
Products
Resources
Contact
Overview
Latest
Regional
Mainland China
Japan
Korea
Indonesia
Malaysia
Singapore
Thailand
Vietnam
Australia
Industry
Auto & Transportation
Business Technology
Consumer Products & Retail
Consumer Technology
Energy
Entertainment & Media
Environment
Financial Services
General Business
Health
Heavy Industry & Manufacturing
Policy & Public Interest
Sports
Telecommunications
Travel
Food and Beverages
Advertising, Marketing and Media
Exhibition
Real Estate and Furniture
Trending Topics
Earnings
Artificial Intelligence
Virtual Reality (VR)
Co-Working Space
Belt & Road
Blockchain
Investment & Financing
Personnel Announcements
World Economic Forum
COVID-19 / Coronavirus
Live Streaming
New Technologies & New Products
Web Summit
Carbon Neutral
China International Consumer Products Expo
Biotech
Summer Event
Environmental, Social, Governance (ESG)
RE+ 2023
UN Climate Change Conference (COP28)
Embedded World
Lunar New Year
Mobile World Congress (MWC)
IFA 2023
Holiday Season
Consumer Electronics Show (CES)
Canton Fair
Earth Day
Fortune Global 500/ Fortune China 500
Asian Games
China International Import Expo
5G
International Women's Day
Auto Shanghai 2023
World Environment Day
Multimedia
Other Languages
Malaysian
Thai
Public Company News
Send a Release
Resources
Products
News
Contact
Overview
Beyond PR Blog
Media Coffee
Client Stories
White Papers
Events in APAC
Media Room
Send a Release
Contact
Products
Resources
News
Asia Pacific Offices
Request More Information
Alert / Newsletter Subscription
Our Presence on Social Media Sites
FAQs
Send a Release
Products
News
Resources
Contact
Send a Release
NEUCLONE PTY LTD
Media Room
Latest News
Photo News
Photo News
Time
All
2019
2018
NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute
2019-05-15 20:13
1887
Report
Share：
Share to wechat：
